BiomX (PHGE) Tax Rate (2018 - 2025)

BiomX (PHGE) posted Tax Rate of 71.01% for Q4 2025, down 216791.6% sequentially from 0.03% in Q3 2025, and down 1546.0% YoY from 4.91% in Q4 2024.

BiomX (PHGE) Tax Rate (2018 - 2025) Analysis & Trends

BiomX has reported Tax Rate for 7 years, with the latest figure at 71.01% in Q4 2025.

Quarterly Tax Rate fell 1546.0% year-over-year to 71.01% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 62.58% (up 8685.0% YoY) and the FY2025 annual result came in at 62.58%, up 16853.0% from the prior year.
Tax Rate slipped to 71.01% in Q4 2025 per PHGE's latest filing, from 0.03% in the prior quarter.
Over five years, Tax Rate peaked at 2.44% in Q4 2022 and troughed at 71.01% in Q4 2025.
A 5-year average of 6.97% and a median of 0.1% in 2021 frame the typical range for Tax Rate.
The sharpest annual moves came in 2022 and 2024: Tax Rate surged 293 bps in 2022, then plunged 5553 bps in 2024.
Over 5 years, Tax Rate stood at 0.49% in 2021, then surged by 598 bps to 2.44% in 2022, then tumbled by 101 bps to 0.02% in 2023, then plunged by 304855 bps to 55.55% in 2024, then slipped by 28 bps to 71.01% in 2025.
According to Business Quant data, Tax Rate over the past three periods registered 71.01%, 0.03%, and 0.03% for Q4 2025, Q3 2025, and Q2 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Tax Rate (Qtr)
1	Vertex Pharmaceuticals	137.11 Bn	129.26 Bn	2.84 Bn	20.98%
2	Regeneron Pharmaceuticals	84.98 Bn	76.99 Bn	3.93 Bn	15.11%
3	Argenx Se	64.52 Bn	59.33 Bn	1.37 Bn	10.91%
4	Moderna	53.23 Bn	48.09 Bn	52.00 Mn	-1.96%
5	BeOne Medicines	41.23 Bn	36.14 Bn	1.53 Bn	24.15%
6	Alnylam Pharmaceuticals	30.65 Bn	27.34 Bn	992.69 Mn	7.49%
7	Insmed	27.15 Bn	25.99 Bn	358.27 Mn	-16.71%
8	Royalty Pharma	26.98 Bn	26.14 Bn	-	-
9	BioNTech SE	26.78 Bn	8.39 Bn	668.28 Mn	34.12%
10	BiomX	361,408.40	-806,591.60	-	-

Download Data